Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WR9U
|
|||
| Drug Name |
MEDI7352
|
|||
| Indication | Diabetic neuropathy [ICD-11: 8C0Z] | Phase 2 | [1] | |
| Osteoarthritis [ICD-11: FA00-FA05] | Phase 1 | [2] | ||
| Pain [ICD-11: MG30-MG3Z] | Phase 1 | [2] | ||
| Company |
MedImmune Gaithersburg, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03755934) Efficacy and Safety of MEDI7352 in Subjects With Painful Diabetic Neuropathy. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.